NEW YORK (GenomeWeb News) – Shimadzu said today that it has registered several of its HPLC and LC-MS instruments as Class I medical devices with the US Food and Drug Administration, allowing them to be used in clinical settings.

The registration covers Shimadzu's LC-20 CL and LC-30 CL HPLCs; LC-MS-2020 CL single quadrupole mass spec; and LC-MS-8030 CL, LC-MS-8040 CL, and LC-MS-8050 CL triple quadrupole mass specs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.